CSIMarket
 


Penumbra Inc   (PEN)
Other Ticker:  
 

Penumbra Inc 's Leverage Ratio

PEN's quarterly Leverage Ratio and Total Liabilities, Equity growth


Despite a net increase in borrowings by 3.6%, Penumbra Inc managed to enhance Leverage Ratio in the forth quarter 2023 to 0.32, surpassing the average for Penumbra Inc 's Leverage Ratio.

Within Medical Equipment & Supplies industry in the forth quarter 2023, 11 other companies have achieved lower Leverage Ratio than Penumbra Inc in the IV Quarter 2023. While Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 168, from total ranking in the third quarter 2023 at 271 .

Explain Leverage Ratio?
Who are PEN Customers?
What are PEN´s Total Liabilities?


PEN Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change 18.03 % 13.39 % 9.95 % 6.79 % 4.71 %
Y / Y Total Liabilities Change 1.43 % 4.71 % 2.26 % 8.34 % 28.14 %
Leverage Ratio MRQ 0.32 0.33 0.34 0.36 0.37
PEN's Total Ranking # 168 # 271 # 225 # 223 # 276
Seq. Equity Change 6.78 % 3.52 % 4.11 % 2.56 % 2.58 %
Seq. Total Liabilities Change 3.6 % -0.48 % -1.31 % -0.32 % 6.95 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 49
Overall Market # 168


Leverage Ratio Statistics
High Average Low
0.41 0.25 0.12
(Sep 30 2021)   (Jun 30 2017)




Financial Statements
Penumbra Inc 's Equity $ 1,179 Millions Visit PEN's Balance sheet
Penumbra Inc 's Total Liabilities $ 377 Millions Visit PEN's Balance sheet
Source of PEN's Sales Visit PEN's Sales by Geography


Cumulative Penumbra Inc 's Leverage Ratio

PEN's Leverage Ratio for the trailling 12 Months

PEN Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth 18.03 % 13.39 % 9.95 % 6.79 % 4.71 %
Y / Y Total Liabilities TTM Growth 1.43 % 4.71 % 2.26 % 8.34 % 28.14 %
Leverage Ratio TTM 0.34 0.35 0.36 0.37 0.36
Total Ranking TTM # 389 # 716 # 791 # 859 # 1009
Seq. Equity TTM Growth 6.78 % 3.52 % 4.11 % 2.56 % 2.58 %
Seq. Total Liabilities TTM Growth 3.6 % -0.48 % -1.31 % -0.32 % 6.95 %


On the trailing twelve months basis Despite of the net new borrowings of 3.6% during the twelve months period ending in IV Quarter 2023 Penumbra Inc has managed to decrease Leverage Ratio in the IV Quarter 2023 to 0.34, above the PEN's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry PEN recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 1, from total ranking in previous 12 month period at 654.

Explain Leverage Ratio?
Who are PEN Customers?
What are PEN´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 0
Healthcare Sector # 1
Within the Market # 168


trailing twelve months Leverage Ratio Statistics
High Average Low
0.37 0.28 0.14
(Mar 31 2023)   (Jun 30 2017)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
Genedx Holdings Corp   0.84 $ 190.739  Millions$ 228.017  Millions
Innovage Holding Corp   0.84 $ 243.121  Millions$ 291.141  Millions
Steris Plc  0.78 $ 4,983.048  Millions$ 6,428.099  Millions
Silk Road Medical Inc   0.76 $ 114.158  Millions$ 151.151  Millions
Medtronic Plc  0.75 $ 39,044.000  Millions$ 51,996.000  Millions
Privia Health Group Inc   0.71 $ 430.174  Millions$ 607.389  Millions
Boston Scientific Corporation  0.70 $ 13,752.000  Millions$ 19,530.000  Millions
Align Technology inc   0.68 $ 2,453.388  Millions$ 3,630.489  Millions
Mimedx Group Inc   0.67 $ 96.330  Millions$ 142.717  Millions
Docgo Inc   0.62 $ 189.657  Millions$ 305.171  Millions
Odyssey Health Inc   0.62 $ 5.380  Millions$ 8.670  Millions
Pro dex Inc   0.62 $ 19.641  Millions$ 31.786  Millions
Teleflex Incorporated  0.57 $ 2,524.178  Millions$ 4,440.988  Millions
Precision Optics Corporation Inc   0.55 $ 6.232  Millions$ 11.317  Millions
Resmed Inc   0.54 $ 2,423.234  Millions$ 4,481.854  Millions
Envista Holdings Corporation  0.52 $ 2,178.900  Millions$ 4,173.900  Millions
Modular Medical Inc   0.52 $ 1.992  Millions$ 3.845  Millions
Cvrx inc  0.52 $ 39.282  Millions$ 75.947  Millions
Pulmonx Corporation  0.50 $ 59.466  Millions$ 118.315  Millions
Inovio Pharmaceuticals Inc   0.46 $ 53.602  Millions$ 117.349  Millions
Inari Medical Inc   0.45 $ 209.325  Millions$ 464.910  Millions
Alcon inc   0.44 $ 8,990.000  Millions$ 20,624.000  Millions
Warby Parker Inc   0.43 $ 128.354  Millions$ 301.787  Millions
Ufp Technologies Inc   0.41 $ 118.045  Millions$ 286.091  Millions
Profound Medical Corp   0.41 $ 12.731  Millions$ 31.180  Millions
Edwards Lifesciences Corporation  0.40 $ 2,713.200  Millions$ 6,719.400  Millions
Koru Medical Systems Inc  0.40 $ 8.107  Millions$ 20.354  Millions
Orchestra Biomed Holdings Inc   0.37 $ 25.482  Millions$ 68.043  Millions
Aethlon Medical Inc   0.37 $ 2.825  Millions$ 7.611  Millions
Nephros Inc   0.37 $ 3.057  Millions$ 8.358  Millions

Date modified: 2024-02-23T13:13:41+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com